Frailty changes after ovarian cancer diagnosis in older women
In the first year after diagnosis, 38% maintained their frailty status, 4% improved, 26% worsened and 32% died.
Our read
Populations- Studied:
- Cohort study of 24,725 older women with ovarian cancer, 1-3 years
- What changed:
- During year 1 after diagnosis, 38% maintained frailty status, 4% improved, 26% worsened, and 32% died
- The catch:
- Frailty was estimated from billing records rather than direct clinical assessments
Editor of record: Boris Djordjevic · AgingResearch.News
Among 24,725 women aged 65 or older diagnosed with ovarian cancer between 2000 and 2019, an observational study tracked frailty and survival using linked cancer-registry and Medicare records. Researchers measured frailty—a reduced ability to withstand illness or other stresses—using a validated index based on medical billing records at diagnosis and one to three years later.
Current frailty was more strongly associated with survival than frailty at diagnosis, and that association strengthened over time. Frailty at diagnosis was not associated with survival after the analysis accounted for current frailty. There were 21,309 deaths during a median follow-up of 25 months. The authors recommended incorporating repeated frailty assessments into clinical practice.
Why it matters
Leading oncology societies recommend assessing frailty before cancer treatment in older adults. These findings address whether care decisions should also draw on assessments after diagnosis.
Caveats
Frailty was estimated from medical billing records rather than direct clinical assessments. The cohort included only women aged 65 or older with ovarian cancer.
The paper
Longitudinal dynamics of post-diagnosis frailty among older women with ovarian cancer
University of Wisconsin–Madison
Gynecologic Oncology, May 12, 2026, Open access

Comments
Be the first to comment.